Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Schizophrenia

  Free Subscription


Articles published in J Clin Psychiatry

Retrieve available abstracts of 38 articles:
HTML format
Text format



Single Articles


    July 2019
  1. NIA AB, Mann CL, Spriggs S, DeFrancisco DR, et al
    The Relevance of Sex in the Association of Synthetic Cannabinoid Use With Psychosis and Agitation in an Inpatient Population.
    J Clin Psychiatry. 2019;80.
    PubMed     Text format     Abstract available


    April 2019
  2. KANE JM, Schooler NR, Marcy P, Achtyes ED, et al
    Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics): Results From the Recruitment Phase of the PRELAPSE Trial.
    J Clin Psychiatry. 2019;80.
    PubMed     Text format     Abstract available


  3. CUI Y, Kim SW, Lee BJ, Kim JJ, et al
    Negative Schema and Rumination as Mediators of the Relationship Between Childhood Trauma and Recent Suicidal Ideation in Patients With Early Psychosis.
    J Clin Psychiatry. 2019;80.
    PubMed     Text format     Abstract available


    March 2019
  4. LAURIELLO J, Perkins DO
    Managing Transitions in Care and Adherence to Improve Outcomes in Schizophrenia.
    J Clin Psychiatry. 2019;80.
    PubMed     Text format     Abstract available


  5. FADEN J
    Treatment-Resistant Schizophrenia: A Brief Overview of Treatment Options.
    J Clin Psychiatry. 2019;80.
    PubMed     Text format    


  6. KANE JM, Agid O, Baldwin ML, Howes O, et al
    Clinical Guidance on the Identification and Management of Treatment-Resistant Schizophrenia.
    J Clin Psychiatry. 2019;80.
    PubMed     Text format     Abstract available


    February 2019
  7. LAURIELLO J, Perkins DO
    Enhancing the Treatment of Patients With Schizophrenia Through Continuous Care.
    J Clin Psychiatry. 2019;80.
    PubMed     Text format     Abstract available


    January 2019
  8. GORDON JA
    NIMH Supports Evidence-Based Treatments for Schizophrenia: A Response to Torrey et al.
    J Clin Psychiatry. 2019;80.
    PubMed     Text format    


  9. TORREY EF, Yolken RH, Lamb HR
    NIMH Drug Trials for Schizophrenia.
    J Clin Psychiatry. 2019;.
    PubMed     Text format    


  10. CORRELL CU, Potkin SG, Zhong Y, Harsanyi J, et al
    Long-Term Remission With Cariprazine Treatment in Patients With Schizophrenia: A Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Trial.
    J Clin Psychiatry. 2019;80.
    PubMed     Text format     Abstract available


    December 2018
  11. KUMAGAI F, Suzuki T, Fleischhacker WW, Yasui-Furukori N, et al
    Early Placebo Improvement Is a Marker for Subsequent Placebo Response in Long-Acting Injectable Antipsychotic Trials for Schizophrenia: Combined Analysis of 4 RCTs.
    J Clin Psychiatry. 2018;80.
    PubMed     Text format     Abstract available


    September 2018
  12. ANDRADE C
    The Use of Statins for Antipsychotic Augmentation in Schizophrenia: Examination of Meta-Analyses With Flawed Methods and Conclusions.
    J Clin Psychiatry. 2018;79.
    PubMed     Text format     Abstract available


  13. GODIN O, Leboyer M, Schurhoff F, Llorca PM, et al
    Metabolic Syndrome and Illness Severity Predict Relapse at 1-Year Follow-Up in Schizophrenia: The FACE-SZ Cohort.
    J Clin Psychiatry. 2018;79.
    PubMed     Text format     Abstract available


    July 2018
  14. ZHANG XY, Du X, Yin G, Zhang Y, et al
    Prevalence and Clinical Correlates of and Cognitive Function at the Time of Suicide Attempts in First-Episode and Drug-Naive Patients With Schizophrenia.
    J Clin Psychiatry. 2018;79.
    PubMed     Text format     Abstract available


  15. CHENGAPPA KNR, Brar JS, Gannon JM, Schlicht PJ, et al
    Adjunctive Use of a Standardized Extract of Withania somnifera (Ashwagandha) to Treat Symptom Exacerbation in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study.
    J Clin Psychiatry. 2018;79.
    PubMed     Text format     Abstract available


    June 2018
  16. EMSLEY R, Nuamah I, Gopal S, Hough D, et al
    Relapse After Antipsychotic Discontinuation in Schizophrenia as a Withdrawal Phenomenon vs Illness Recurrence: A Post Hoc Analysis of a Randomized Placebo-Controlled Study.
    J Clin Psychiatry. 2018;79.
    PubMed     Text format     Abstract available


    May 2018
  17. KEEFE RSE, Harvey PD, Khan A, Saoud JB, et al
    Cognitive Effects of MIN-101 in Patients With Schizophrenia and Negative Symptoms: Results From a Randomized Controlled Trial.
    J Clin Psychiatry. 2018;79.
    PubMed     Text format     Abstract available


    April 2018
  18. LEE EE, Martin AS, Tu X, Palmer BW, et al
    Childhood Adversity and Schizophrenia: The Protective Role of Resilience in Mental and Physical Health and Metabolic Markers.
    J Clin Psychiatry. 2018;79.
    PubMed     Text format     Abstract available


  19. HOU CL, Chen MY, Cai MY, Chen ZL, et al
    Antipsychotic-Free Status in Community-Dwelling Patients With Schizophrenia in China: Comparisons Within and Between Rural and Urban Areas.
    J Clin Psychiatry. 2018;79.
    PubMed     Text format     Abstract available


    March 2018
  20. TAKEUCHI H, Fathi A, Thiyanavadivel S, Agid O, et al
    Can Aripiprazole Worsen Psychosis in Schizophrenia? A Meta-Analysis of Double-Blind, Randomized, Controlled Trials.
    J Clin Psychiatry. 2018;79.
    PubMed     Text format     Abstract available


    November 2017
  21. TSOUTSOULAS C, Mulsant BH, Kumar S, Ghazala Z, et al
    Anticholinergic Burden and Cognition in Older Patients With Schizophrenia.
    J Clin Psychiatry. 2017 Nov 28. doi: 10.4088/JCP.17m11523.
    PubMed     Text format     Abstract available


  22. ANDRADE C
    Memantine as an Augmentation Treatment for Schizophrenia: Limitations of Meta-Analysis for Evidence-Based Evaluation of Research.
    J Clin Psychiatry. 2017 Nov 21. doi: 10.4088/JCP.17f11998.
    PubMed     Text format     Abstract available


  23. DEAN DJ, Bryan AD, Newberry R, Gupta T, et al
    A Supervised Exercise Intervention for Youth at Risk for Psychosis: An Open-Label Pilot Study.
    J Clin Psychiatry. 2017 Nov 21. doi: 10.4088/JCP.16m11365.
    PubMed     Text format     Abstract available


  24. MEKORI-DOMACHEVSKY E, Taler M, Shoenfeld Y, Gurevich M, et al
    Elevated Proinflammatory Markers in 22q11.2 Deletion Syndrome Are Associated With Psychosis and Cognitive Deficits.
    J Clin Psychiatry. 2017 Nov 14. pii: 16m11207. doi: 10.4088/JCP.16m11207.
    PubMed     Text format     Abstract available


  25. TINKELMAN A, Hill EA, Deligiannidis KM
    Management of New Onset Psychosis in the Postpartum Period.
    J Clin Psychiatry. 2017 Nov 7. pii: 17ac11880. doi: 10.4088/JCP.17ac11880.
    PubMed     Text format    


  26. DOWNS JM, Lechler S, Dean H, Sears N, et al
    The Association Between Comorbid Autism Spectrum Disorders and Antipsychotic Treatment Failure in Early-Onset Psychosis: A Historical Cohort Study Using Electronic Health Records.
    J Clin Psychiatry. 2017 Nov 7. pii: 16m11422. doi: 10.4088/JCP.16m11422.
    PubMed     Text format     Abstract available


  27. PERKINS DO
    Improving Long-Term Outcomes in Patients With Schizophrenia: What Is the Evidence for Long-Acting Injectable Antipsychotics?
    J Clin Psychiatry. 2017;78:e1431.
    PubMed     Text format     Abstract available


    September 2017
  28. MCEVOY JP, Risinger R, Mykhnyak S, Du Y, et al
    Durability of Therapeutic Response With Long-Term Aripiprazole Lauroxil Treatment Following Successful Resolution of an Acute Episode of Schizophrenia.
    J Clin Psychiatry. 2017 Sep 19. pii: 17m11625. doi: 10.4088/JCP.17m11625.
    PubMed     Text format     Abstract available


  29. HAIG GM, Wang D, Zhao J, Othman AA, et al
    Efficacy and Safety of the alpha7-Nicotinic Acetylcholine Receptor Agonist ABT-126 in the Treatment of Cognitive Impairment Associated With Schizophrenia: Results From a Phase 2b Randomized Controlled Study in Smokers.
    J Clin Psychiatry. 2017 Sep 12. pii: 16m11162. doi: 10.4088/JCP.16m11162.
    PubMed     Text format     Abstract available


  30. PUIG O, Baeza I, de la Serna E, Cabrera B, et al
    Persistent Negative Symptoms in First-Episode Psychosis: Early Cognitive and Social Functioning Correlates and Differences Between Early and Adult Onset.
    J Clin Psychiatry. 2017 Sep 12. pii: 16m11122. doi: 10.4088/JCP.16m11122.
    PubMed     Text format     Abstract available


  31. SULTAN RS, Olfson M, Correll CU, Duncan EJ, et al
    Evaluating the Effect of the Changes in FDA Guidelines for Clozapine Monitoring.
    J Clin Psychiatry. 2017;78:e933-e939.
    PubMed     Text format     Abstract available


    June 2017
  32. WEIDEN PJ, Kim E, Bermak J, Turkoz I, et al
    Does Half-Life Matter After Antipsychotic Discontinuation? A Relapse Comparison in Schizophrenia With 3 Different Formulations of Paliperidone.
    J Clin Psychiatry. 2017 Jun 20. pii: 16m11308. doi: 10.4088/JCP.16m11308.
    PubMed     Text format     Abstract available


    May 2017
  33. WEISER M, Levi L, Burshtein S, Hagin M, et al
    Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled Trial.
    J Clin Psychiatry. 2017 May 23. pii: 15m10498. doi: 10.4088/JCP.15m10498.
    PubMed     Text format     Abstract available


  34. TOSATO S, Albert U, Tomassi S, Iasevoli F, et al
    A Systematized Review of Atypical Antipsychotics in Pregnant Women: Balancing Between Risks of Untreated Illness and Risks of Drug-Related Adverse Effects.
    J Clin Psychiatry. 2017;78:e477-e489.
    PubMed     Text format     Abstract available


  35. BERNARDINI F, Attademo L, Cleary SD, Luther C, et al
    Risk Prediction Models in Psychiatry: Toward a New Frontier for the Prevention of Mental Illnesses.
    J Clin Psychiatry. 2017;78:572-583.
    PubMed     Text format     Abstract available


    April 2017
  36. HAGEN JM, Sutterland AL, Koeter MW, Lutter R, et al
    Advanced Glycation End Products in Recent-Onset Psychosis Indicate Early Onset of Cardiovascular Risk.
    J Clin Psychiatry. 2017 Apr 25. doi: 10.4088/JCP.16m10972.
    PubMed     Text format     Abstract available


    March 2017
  37. ZHENG W, Xiang YT, Yang XH, Xiang YQ, et al
    Clozapine Augmentation With Antiepileptic Drugs for Treatment-Resistant Schizophrenia: A Meta-Analysis of Randomized Controlled Trials.
    J Clin Psychiatry. 2017 Mar 28. doi: 10.4088/JCP.16r10782.
    PubMed     Text format     Abstract available


    February 2017
  38. TAKEUCHI H, Lee J, Fervaha G, Foussias G, et al
    Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial.
    J Clin Psychiatry. 2017;78:223-228.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: